Cover Image
市場調查報告書

Cadila Pharmaceuticals Ltd.的產品平台分析

Cadila Pharmaceuticals Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 192513
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
Cadila Pharmaceuticals Ltd.的產品平台分析 Cadila Pharmaceuticals Ltd. - Product Pipeline Review - 2014
出版日期: 2014年05月30日 內容資訊: 英文 28 Pages
簡介

Cadila Pharmaceuticals Ltd.這個學名藥企業主要在提供人類用及動物用的醫藥品、生物產品、診斷套件、醫藥品原料藥(API)及植物組織培養產品。該公司的產品有止痛藥,造血劑,抗感染疾病,心血管系統,眼科,消化器官系統,呼吸系統,抗糖尿病,抗生素,免疫疾病系等,廣泛用於各種應用上。

本報告提供Cadila Pharmaceuticals Ltd.上的治療藥開發平台現狀及各開發階段比較分析,提供藥物標的,作用機制,給藥途徑,各類型分子的治療藥評估,以及最新的企業新聞和發表,後期階段及中止計劃的相關資訊等。

Cadila Pharmaceuticals Ltd.的基本資料

Cadila Pharmaceuticals Ltd.概要

  • 主要資訊
  • 企業資料

Cadila Pharmaceuticals Ltd.:R&D概要

  • 主要的治療範圍

Cadila Pharmaceuticals Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Cadila Pharmaceuticals Ltd.:開發中產品概況

  • 位於最終階段的開發中產品
    • 位於第三階段的產品/聯合治療模式
  • 位於臨床實驗階段的開發中產品
    • 位於第二階段的產品/聯合治療模式
    • 位於第一階段的產品/聯合治療模式

Cadila Pharmaceuticals Ltd.:藥物簡介

  • Centatin
  • CADI-05
  • 麻疹活病毒疫苗
  • 麻疹及德國麻疹疫苗

Cadila Pharmaceuticals Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各類型分子
  • 各作用機制

Cadila Pharmaceuticals Ltd.:最近的開發平台趨勢

Cadila Pharmaceuticals Ltd.:暫停中的計劃

Cadila Pharmaceuticals Ltd.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC04888CDB

Global Markets Direct's, 'Cadila Pharmaceuticals Ltd. - Product Pipeline Review - 2014', provides an overview of the Cadila Pharmaceuticals Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Cadila Pharmaceuticals Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Cadila Pharmaceuticals Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Cadila Pharmaceuticals Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Cadila Pharmaceuticals Ltd.'s pipeline products

Reasons to buy

  • Evaluate Cadila Pharmaceuticals Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Cadila Pharmaceuticals Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Cadila Pharmaceuticals Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Cadila Pharmaceuticals Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cadila Pharmaceuticals Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Cadila Pharmaceuticals Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Cadila Pharmaceuticals Ltd. Snapshot
    • Cadila Pharmaceuticals Ltd. Overview
    • Key Information
    • Key Facts
  • Cadila Pharmaceuticals Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Cadila Pharmaceuticals Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
    • Cadila Pharmaceuticals Ltd. - Pipeline Products Glance
      • Cadila Pharmaceuticals Ltd. - Late Stage Pipeline Products
        • Phase III Products/Combination Treatment Modalities
      • Cadila Pharmaceuticals Ltd. - Clinical Stage Pipeline Products
        • Phase II Products/Combination Treatment Modalities
        • Phase I Products/Combination Treatment Modalities
    • Cadila Pharmaceuticals Ltd. - Drug Profiles
      • Centatin
        • Product Description
        • Mechanism of Action
        • R&D Progress
      • CADI-05
        • Product Description
        • Mechanism of Action
        • R&D Progress
      • Live Measles Vaccine
        • Product Description
        • Mechanism of Action
        • R&D Progress
      • Measles and Rubella Vaccine
        • Product Description
        • Mechanism of Action
        • R&D Progress
    • Cadila Pharmaceuticals Ltd. - Pipeline Analysis
      • Cadila Pharmaceuticals Ltd. - Pipeline Products by Target
      • Cadila Pharmaceuticals Ltd. - Pipeline Products by Route of Administration
      • Cadila Pharmaceuticals Ltd. - Pipeline Products by Molecule Type
      • Cadila Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action
    • Cadila Pharmaceuticals Ltd. - Recent Pipeline Updates
    • Cadila Pharmaceuticals Ltd. - Dormant Projects
    • Cadila Pharmaceuticals Ltd. - Locations And Subsidiaries
      • Head Office
      • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Cadila Pharmaceuticals Ltd., Key Information
  • Cadila Pharmaceuticals Ltd., Key Facts
  • Cadila Pharmaceuticals Ltd. - Pipeline by Indication, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2014
  • Cadila Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2014
  • Cadila Pharmaceuticals Ltd. - Partnered Products in Pipeline, 2014
  • Cadila Pharmaceuticals Ltd. - Partnered Products/ Combination Treatment Modalities, 2014
  • Cadila Pharmaceuticals Ltd. - Phase III, 2014
  • Cadila Pharmaceuticals Ltd. - Phase II, 2014
  • Cadila Pharmaceuticals Ltd. - Phase I, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Target, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Cadila Pharmaceuticals Ltd. - Recent Pipeline Updates, 2014
  • Cadila Pharmaceuticals Ltd. - Dormant Developmental Projects,2014
  • Cadila Pharmaceuticals Ltd., Other Locations

List of Figures

  • Cadila Pharmaceuticals Ltd. - Pipeline by Top 10 Indication, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2014
  • Cadila Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2014
  • Cadila Pharmaceuticals Ltd. - Partnered Products in Pipeline, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Top 10 Target, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Cadila Pharmaceuticals Ltd. - Pipeline by Top 10 Molecule Type, 2014
Back to Top